Ka Hale Pomaikai

Ka Hale Pomaikai, based in Kaunakakai, HI, is one of the SAMHSA-registered treatment programs operating in HI. The facility's programming is outpatient (IOP, MAT), not residential. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Ka Hale Pomaikai

On care levels specifically: Ka Hale Pomaikai is an outpatient-focused program (IOP, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What that means in practice is that matching Ka Hale Pomaikai to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

On insurance specifically: Payment and insurance specifics for Ka Hale Pomaikai are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Criminal justice (other than DUI/DWI)/Forensic clients. If that matches what you or your family member need, great — and worth asking specifically about what the programming looks like day-to-day (how many hours per week of specialty-specific content, who leads it, what credentials they hold).

Before you call

Before admission to Ka Hale Pomaikai, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.